| CYHB2250454 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs | Supplementary Application | 2022-07-21 | | Beijing Beilu Pharmaceutical Co Ltd | | | view |
| CYHS2500856 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs(4) | Generic Drug | 2025-02-27 | | Zhejiang Hisoar Pharmaceutical Co Ltd | | | view |
| CYHB2101115 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs | Supplementary Application | 2021-04-14 | | Beijing Foyou Pharma Co Ltd | | | view |
| CYHS2401380 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs(4) | Generic Drug | 2024-05-09 | | Chengdu Hengrui Pharmaceutical Co Ltd | | | view |
| JYHB1300747 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs | Supplementary Application | 2013-06-18 | | Boehringer Ingelheim Pharma Gmbh & Co KG;Novo Nordisk A/S | Certificate Issued | 2014-01-21 | view |
| JYHZ2100648 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs | License Renew | 2021-10-12 | | Novo Nordisk (China) Pharmaceuticals Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG;Novo Nordisk A/S | | | view |
| CYHS2403754 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs(4) | Generic Drug | 2024-11-05 | | Jilin Huisheng Biopharmaceutical Co Ltd;Nanjing Healthnice Pharmaceutical Co Ltd | | | view |
| CYHB2101117 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs | Supplementary Application | 2021-04-14 | | Beijing Foyou Pharma Co Ltd | | | view |
| CYHS2302990 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs(4) | Generic Drug | 2023-11-03 | | Guangdong Pidi Pharmaceutical Co Ltd | | | view |
| JYHB1100942 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs | Supplementary Application | 2011-10-25 | | Boehringer Ingelheim Pharma Gmbh & Co KG;Novo Nordisk A/S | Certificate Issued | 2013-02-22 | view |
| CYHS2403753 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs(4) | Generic Drug | 2024-11-05 | | Jilin Huisheng Biopharmaceutical Co Ltd;Nanjing Healthnice Pharmaceutical Co Ltd | | | view |
| JYHB1300743 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs | Supplementary Application | 2013-06-18 | | Boehringer Ingelheim Pharma Gmbh & Co KG;Novo Nordisk A/S | Certificate Issued | 2014-01-21 | view |
| CYHS2302442 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs(4) | Generic Drug | 2023-09-11 | | Tonghua Wantong Pharmaceutical STOCK Co Ltd | | | view |
| JYHB1100941 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs | Supplementary Application | 2011-10-25 | | Boehringer Ingelheim Pharma Gmbh & Co KG;Novo Nordisk A/S | Certificate Issued | 2013-02-22 | view |
| JYHZ2100647 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs | License Renew | 2021-10-12 | | Novo Nordisk (China) Pharmaceuticals Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG;Novo Nordisk A/S | | | view |
| JYHB1300748 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs | Supplementary Application | 2013-06-18 | | Boehringer Ingelheim Pharma Gmbh & Co KG;Novo Nordisk A/S | Certificate Issued | 2014-01-21 | view |
| CYHS2201243 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs(4) | Generic Drug | 2022-08-05 | | Zhejiang Hisoar Pharmaceutical Co Ltd | | | view |
| JYHB1100940 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs | Supplementary Application | 2011-10-25 | | Boehringer Ingelheim Pharma Gmbh & Co KG;Novo Nordisk A/S | Certificate Issued | 2013-02-22 | view |
| CYHS2101284 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs(4) | Generic Drug | 2021-06-11 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CYHS2403752 | 瑞格列奈片 | repaglinide | Tablet | Chemical Drugs(4) | Generic Drug | 2024-11-05 | | Jilin Huisheng Biopharmaceutical Co Ltd;Nanjing Healthnice Pharmaceutical Co Ltd | | | view |
